Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy (English)
- New search for: Krenning, E. P.
- New search for: De Jong, M.
- New search for: Kooij, P. P. M.
- New search for: Breeman, W. A. P.
- New search for: Bakker, W. H.
- New search for: De Herder, W. W.
- New search for: Van Eijck, C. H. J.
- New search for: Kwrekkeboom, D. J.
- New search for: Jamar, F.
- New search for: Pauwels, S.
- New search for: Krenning, E. P.
- New search for: De Jong, M.
- New search for: Kooij, P. P. M.
- New search for: Breeman, W. A. P.
- New search for: Bakker, W. H.
- New search for: De Herder, W. W.
- New search for: Van Eijck, C. H. J.
- New search for: Kwrekkeboom, D. J.
- New search for: Jamar, F.
- New search for: Pauwels, S.
- New search for: Oeberg, K.
In:
Neuroendocrine Tumours: Present Status and Future Directions of Somatostatin Analogue Therapy
;
23-30
;
1999
-
ISSN:
- Article (Journal) / Print
-
Title:Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy
-
Contributors:Krenning, E. P. ( author ) / De Jong, M. ( author ) / Kooij, P. P. M. ( author ) / Breeman, W. A. P. ( author ) / Bakker, W. H. ( author ) / De Herder, W. W. ( author ) / Van Eijck, C. H. J. ( author ) / Kwrekkeboom, D. J. ( author ) / Jamar, F. ( author ) / Pauwels, S. ( author )
-
Published in:Neuroendocrine Tumours: Present Status and Future Directions of Somatostatin Analogue Therapy ; 23-30ANNALS OF ONCOLOGY ; 10 ; 23-30
-
Publisher:
- New search for: KLUWER ACADEMIC PUBLISHERS GROUP
-
Publication date:1999-01-01
-
Size:8 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.992
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.992 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 10
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
The First Central European Oncology Congress, Opatija, Croatia, 1998Sikic, B. I. et al. | 1999
- 1
-
Pancreatico-biliary malignancy: Prevalence and risk factorsLowenfels, A. B. / Maisonneuve, P. et al. | 1999
- 3
-
Surgery during chemotherapy and at relapse of ovarian cancerBerek, J. S. / Trope, C. / Vergote, I. et al. | 1999
- 3
-
Reflections on oncology in Central and Eastern EuropeEckhardt, S. et al. | 1999
- 3
-
The epidemiology of lung cancerFranceschi, S. / Bidoli, E. et al. | 1999
- 3
-
Neuroendocrine gastrointestinal tumors - a condensed overview of diagnosis and treatmentOeberg, K. et al. | 1999
- 4
-
Progress in cancer genetics: Lessons from pancreatic cancerGoggins, M. / Kern, S. E. / Offerhaus, J. A. / Hruban, R. H. et al. | 1999
- 7
-
Molecular epidemiology of lung cancerShields, P. G. et al. | 1999
- 8
-
H.A. Reber (ed): Pancreatic cancer. Pathogenesis, diagnosis, and treatmentNole, F. et al. | 1999
- 9
-
Pathology of incipient pancreatic cancerHruban, R. H. / Wilentz, R. E. / Goggins, M. et al. et al. | 1999
- 9
-
The European Society for Medical Oncology (ESMO) and its activities through the Central Eastern European Task ForceHansen, H. H. / Bjerre-Jepsen, M. / Hossfeld, D. et al. | 1999
- 9
-
The first decadeCavalli, E. et al. | 1999
- 9
-
Ovarian cancer: should we be managing patients with good and bad prognostic factors in the same manner?Eisenhauer, E. A. / Gore, M. / Neijt, J. P. et al. | 1999
- 9
-
Clinicopathological profile as a basis for classification of the endocrine tumours of the gastroenteropancreatic tractSolcia, E. / Rindi, G. / Paolotti, D. / La Rosa, S. / Capella, C. / Fiocca, R. et al. | 1999
- 11
-
Arc physicians aware of what patients know about what physicians know?Sabbioni, M. E. E. et al. | 1999
- 12
-
Computed tomography in the diagnosis and staging of cholangiocarcinoma and pancreatic carcinomaFreeny, P. C. et al. | 1999
- 13
-
The combination of etoposide and cisplatin in non-small-cell lung cancer (NSCLC)Ardizzoni, A. / Antonelli, G. / Grossi, F. et al. et al. | 1999
- 13
-
International Consensus Conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: Report of the juryShipp, M. A. / Abeloff, M. D. / Antman, K. H. / Carroll, G. / Hagenbeek, A. / Loeffler, M. / Montserrat, E. / Radford, J. A. / Salles, G. / Schmitz, N. et al. | 1999
- 15
-
The pharmaceutical industry and oncology in Central and Eastern EuropeBen-Am, M. / Gemperli, B. / Covelli, A. / Burke, G. et al. | 1999
- 17
-
Somatostatin receptors present knowledge and future directionsSchonbrunn, A. et al. | 1999
- 17
-
How long should first-line chemotherapy continue?Bertelsen, K. / Grenman, S. / Rustin, G. J. S. et al. | 1999
- 18
-
MRI and MRCP in pancreaticobiliary malignancyFerrucci, J. T. et al. | 1999
- 19
-
Progress in the non-Hodgkin's lymphomasYuen, A. R. et al. | 1999
- 19
-
Anthracyclines in non-small-cell lung cancer: Do they have a therapeutic role?Martoni, A. / Guaraldi, M. / Piana, F. et al. | 1999
- 20
-
Imaging and staging of biliopancreatic malignancy: Role of ultrasoundStairs, N. J. / Reeders, J. W. A. J. et al. | 1999
- 21
-
Use of tumour markers in monitoring the course of ovarian cancerRustin, G. J. S. / Nelstrop, A. E. / Bentzen, S. M. / Piccart, M. J. / Bertelsen, K. et al. | 1999
- 21
-
Dendritic cells: A novel therapeutic modalityLuykx-de Bakker, S. A. / De Gruijl, T. D. / Scheper, R. J. / Wagstaff, J. / Pinedo, H. M. et al. | 1999
- 23
-
Treatment of Hodgkin's disease: Current strategies of the German Hodgkin's Lymphoma Study GroupSieber, M. / Ruffer, U. / Jostin, A. / Diehl, V. et al. | 1999
- 23
-
Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapyKrenning, E. P. / De Jong, M. / Kooij, P. P. M. / Breeman, W. A. P. / Bakker, W. H. / De Herder, W. W. / Van Eijck, C. H. J. / Kwrekkeboom, D. J. / Jamar, F. / Pauwels, S. et al. | 1999
- 25
-
Imaging and staging of bilio-pancreatic turnouts: Role of endoscopic and intra-ductal ultrasonography and guided cytologyPalazzo, L. et al. | 1999
- 25
-
Ifosfamide in non-small-cell lung cancerRosell, R. / Martin, C. / Bala�a, C. et al. | 1999
- 28
-
^1^8FDG-positron emission tomography in pancreatic cancerZimny, M. / Buell, U. et al. | 1999
- 29
-
The Gynecologic Oncology Group experience in ovarian cancerMcGuire, W. P. / Brady, M. F. / Ozols, R. F. et al. | 1999
- 29
-
Tirapazamine: A new drug producing tumor specific enhancement of platinum-based chemotherapy in non-small-cell lung cancerWouters, B. G. / Wang, L.-H. / Martin Brown, J. et al. | 1999
- 29
-
Applying evidence to the individual patientStraus, S. E. / Sackett, D. L. et al. | 1999
- 31
-
Multiple myeloma: An update on biology and treatmentLudwig, H. / Meran, J. / Zojer, N. et al. | 1999
- 31
-
Summing up 15 years of somatostatin analog therapy in neuroendocrine tumors: Future outlookEriksson, B. / Oberg, K. et al. | 1999
- 33
-
Phase I trial of the combination of daily estra-mustine phosphate and intermittent docetaxel in patients with metastatic hormone refractory prostate carcinomaKreis, W. / Budman, D. R. / Fetten, J. / Gonzales, A. L. / Barile, B. / Vinciguerra, V. et al. | 1999
- 33
-
Laparoscopic staging of biliopancreatic malignancyGouma, D. J. / Nieveeu van Dijkum, E. J. M. / De Wit, L. T. / Ohertop, H. et al. | 1999
- 35
-
First line chemotherapy with carboplatin plus paclitaxel in advanced ovarian cancer a new standard of care?Du Bois, A. / Neijt, J. P. / Thigpen, J. T. et al. | 1999
- 35
-
Docetaxel (Taxotere[R]) in combination chemotherapy and in association with thoracic radiotherapy for the treatment of non-small-cell lung cancerOrnstein, D. L. / Nervi, A. M. / Rigas, J. R. et al. | 1999
- 37
-
Imaging of pancreatic adenocarcinoma with radiolabeled monoclonal antibodiesMariani, G. et al. | 1999
- 39
-
Misunderstanding in cancer patients: Why shoot the messenger?Gattellari, M. / Butow, P. N. / Tattersall, M. H. N. / Dunn, S. M. / MacLeod, C. A. et al. | 1999
- 41
-
In vitro pancreatic carcinogenesisSchmied, B. M. / Ulrich, A. / Matsuzaki, H. et al. et al. | 1999
- 41
-
Vinorelbine (Navelbine[R]) in the treatment of non-small-cell lung cancer: Studies with single-agent therapy and in combination with cisplatinGrallo, R. / Harper, P. / Johnson, S. / Delgado, F. M. et al. | 1999
- 43
-
The role of anthracyclines in epithelial ovarian cancerVermorken, J. B. / Harper, P. G. / Buyse, M. et al. | 1999
- 45
-
Treatment of acute leukemiaLechner, K. / Geissler, K. / Jager, U. / Greinix, H. / Kalhs, P. et al. | 1999
- 46
-
Invasion and metastasis in pancreatic cancerEllenrieder, V. / Adler, G. / Gress, T. M. et al. | 1999
- 47
-
Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: A unicentre randomized trial with a 124-month median follow-upMauriac, L. / MacGrogan, G. / Avril, A. / Durand, M. / Floquet, A. / Debled, M. / Dilhuydy, J. M. / Bonichon, F. et al. | 1999
- 47
-
Vinorelbine (Navelbine[R]) in the treatment of non-small-cell lung cancer: Recent developments in combination chemotherapy and radiotherapyGralla, R. / Harper, P. / Johnson, S. / Delgado, F. M. et al. | 1999
- 51
-
Gemcitabine in the treatment of ovarian cancerHansen, S. W. / Tuxen, M. K. / Sessa, C. et al. | 1999
- 51
-
Mucin gene and antigen expression in biliopancreatic carcinogenesisKim, Y. S. / Gum, J. R. / Crawley, S. C. et al. et al. | 1999
- 53
-
The role of single-agent gemcitabine in the treatment of non-small-cell lung cancerKelly, K. et al. | 1999
- 53
-
Modulation of multidrug resistance (MDR) in hematological malignanciesCovelli, A. et al. | 1999
- 53
-
Cardiac effects of high-dose epirubicin and cyclophosphamide in women with poor prognosis breast cancerBasset, R. L. / Abraham, R. / Bik To, L. / Fox, R. M. / Green, M. D. et al. | 1999
- 55
-
Oxaliplatin in ovarian cancerSessa, C. / Ten Bokkel Huinink, W. W. / Du Bois, A. et al. | 1999
- 56
-
DPC4/SMAD4 gene alterations in human cancer, and their functional implicationsSchutte, M. et al. | 1999
- 57
-
Cisplatin and gemcitabine in non-small-cell lung cancerCartei, G. / Sacco, C. / Sibau, A. et al. et al. | 1999
- 59
-
Fludarabine, cyclophosphamide, and dexamethasone (FluCyD) combination is effective in pre-treated low-grade non-Hodgkin's lymphomaLazzarino, M. / Orlandi, E. / Montillo, M. / Tedeschi, A. / Pagnucco, G. / Astori, C. / Corso, A. / Brusamolino, E. / Simoncini, L. / Morra, E. et al. | 1999
- 59
-
Intraperitoneal treatment and dose-intense therapy in ovarian cancerOzols, R. E. / Gore, M. / Trope, C. / Grenman, S. et al. | 1999
- 60
-
Angiogenesis and anti-angiogenesis: Perspectives for the treatment of solid tumorsVan Hinsbergh, V. W. M. / Collen, A. / Koolwijk, P. et al. | 1999
- 61
-
The role of energy and fat in cancers of the breast and colon-rectum in a Southern European populationFranceschi, S. / Favero, A. et al. | 1999
- 63
-
Paclitaxel-based therapy in non-small-cell lung cancer: Improved third generation chemotherapyGreco, F. A. / Hainsworth, J. D. et al. | 1999
- 64
-
Novel technology for detection of genomic and transcriptional alterations in pancreatic cancerWallrapp, C. / Mueller-Pillasch, F. / Micha, A. et al. et al. | 1999
- 65
-
Is primary CNS lymphoma really becoming more common? A population-based study of incidence, clinicopathological features and outcomes in Alberta from 1975 to 1996Hao, D. / Di Francesco, L. M. / Brasher, P. M. A. / De Metz, C. / Fulton, D. S. / De Angelis, L. M. / Forsyth, P. A. J. et al. | 1999
- 65
-
New non-cytotoxic approaches to ovarian cancerKaye, S. B. / Eisenhauer, E. A. / Hamilton, T. C. et al. | 1999
- 65
-
Once-only sigmoidoscopyCuzick, J. et al. | 1999
- 69
-
Familial pancreatic cancerHruban, R. H. / Petersen, G. M. / Goggins, M. et al. et al. | 1999
- 69
-
Docetaxel (Taxotere[R]) in the neo-adjuvant setting in non-small-cell lung cancerMattson, K. et al. | 1999
- 69
-
Basic research: how much do we know, and what are we likely to learn about ovarian cancer in the near future?Hamilton, T. C. / Berek, J. S. / Kaye, S. B. et al. | 1999
- 71
-
Reduced health-related quality of life among Hodgkin's disease survivors: A comparative study with general population normsLoge, J. H. / Foss Abrahamsen, A. / Ekeberg, O. / Kaasa, S. et al. | 1999
- 71
-
Adjuvant and induction chemotherapy in non-small cell lung cancerPirker, R. / Malayeri, R. / Huber, H. et al. | 1999
- 73
-
The role of surgery in integrated therapies for non-small-cell lung cancerSartori, F. / Bortolotti, L. / Michelon, M. et al. et al. | 1999
- 74
-
The impact of smoking on future pancreatic cancer: A computer simulationMulder, L. / Van Genugten, M. L. L. / Hoogenveen, R. T. et al. et al. | 1999
- 75
-
Randomised trials in ovarian cancer: trial design considerationsBrady, M. F. / Thigpen, J. T. / Vermorken, J. B. / Parmar, M. K. B. et al. | 1999
- 77
-
Chemoradiotherapy interactions and lung toxicityTrott, K.-R. et al. | 1999
- 77
-
Chemotherapy of advanced non-small cell lung cancerJassem, J. et al. | 1999
- 79
-
Bone marrow scintigraphy using Technetium-99m antigranulocyte antibody in malignant lymphomasKrause, T. / Eisenmann, N. / Reinhardt, M. / Bathmann, J. / Altehoefer, C. / Finke, J. / Moser, E. et al. | 1999
- 79
-
Diabetes and the risk of pancreatic cancerGullo, L. et al. | 1999
- 82
-
Vagaries of clinical presentation of pancreatic and biliary tract cancerModelell, I. / Guarner, L. / Malagelada, J. R. et al. | 1999
- 83
-
Multidrug resistance in non-small-cell lung cancerScagliotti, G. V. / Novello, S. / Selvaggi, G. et al. | 1999
- 83
-
Intergroup collaboration in ovarian cancer: a giant step forwardPiccart, M. J. / Stuart, G. C. E. / Cassidy, J. / Bertelsen, K. / Parmar, M. K. B. / Eisenhauer, E. A. / Kaye, S. B. / Trope, C. / Swenerton, K. / Harper, P. et al. | 1999
- 83
-
Treatment of small cell lung cancer patientsZochbauer-Muller, S. / Pirker, R. / Huber, H. et al. | 1999
- 85
-
Differential diagnosis of focal panereatitis and pancreatic cancerVan Gulik, T. M. / Moojen, T. M. / Van Geenen, R. et al. et al. | 1999
- 87
-
Advanced epithelial ovarian cancer: 1998 consensus statementsBerek, J. S. / Bertelsen, K. / Du Bois, A. / Brady, M. F. / Carmichael, J. / Eisenhauer, E. A. / Gore, M. / Grenman, S. / Hamilton, T. C. / Hansen, S. W. et al. | 1999
- 87
-
Therapy of non-small-cell lung cancer (NSCLC) in patients with HIV infectionSpina, M. / Sandri, S. / Serraino, D. et al. et al. | 1999
- 87
-
Psychosocial impact of genetic testing in familial medullary-thyroid carcinoma: A multicentric pilot-evaluationFreyer, G. / Dazord, A. / Schlumberger, M. / Conte-Devolx, B. / Ligneau, B. / Trillet-Lenoir, V. / Lenoir, G. M. et al. | 1999
- 89
-
Primary sclerosing cholangitis and cholangiocarcinoma its it diagnostic and therapeutic dilemmaVan Leeuwen, D. J. / Reeders, J. W. A. J. et al. | 1999
- 91
-
Chemotherapy of non-small-cell lung cancer: Role of erythropoietin in the management of anemiaDel Mastro, L. / Gennari, A. / Donati, S. et al. | 1999
- 93
-
Combined modality therapy of non-small cell lung cancersJuretic, A. / Sobat, H. / Samija, M. et al. | 1999
- 94
-
Choledochal cystic malignanciesBismuth, H. / Krissat, J. et al. | 1999
- 95
-
Retinoids in lung cancer chemoprevention and treatmentToma, S. / Raffo, P. / Isnardi, L. / Palumbo, R. et al. | 1999
- 97
-
The potential of platinum-DNA adduct determination in ex vivo treated tumor fragments for the prediction of sensitivity to cisplatin chemotherapyWelters, M. J. P. / Braakhuis, B. J. M. / Jacobs-Bergmans, A. J. / Kegel, A. / Baan, R. A. / Van der Vijgh, W. J. F. / Fichtinger-Schepman, A. M. J. et al. | 1999
- 99
-
Combined modality therapy of rectal cancersSobat, H. / Juretic, A. / Samija, M. et al. | 1999
- 99
-
Mucin hypersecreting neoplasmsCarr-Locke, D. L. et al. | 1999
- 104
-
Cystic pancreatic neoplasmsRattner, D. W. / Fernandez-del Castillo, C. / Warshaw, A. L. et al. | 1999
- 105
-
Chemotherapy for advanced pancreatic cancer: it may no longer be ignoredCascinu, S. / Graziano, F. / Catalano, G. et al. | 1999
- 105
-
New possibilities in chemotherapy for colorectal cancerBekradda, M. / Cvitkovic, E. et al. | 1999
- 107
-
Rote of tumor markers and mutations in cells and pancreatic juice in the diagnosis of pancreatic cancerTascilar, M. / Caspers, E. / Sturm, P. D. J. et al. et al. | 1999
- 111
-
Detection of micrometastasis in bone marrow of pancreatic cancer patientsThorban, S. / Roder, J. D. / Siewert, J. R. et al. | 1999
- 111
-
Up-regulated pyrimidine nucleoside phosphorylase in breast carcinoma correlates with lymph node metastasisMimori, K. / Ueo, H. / Shirasaka, C. / Shiraishi, T. / Yamagata, M. / Haraguchi, M. / Mori, M. et al. | 1999
- 113
-
BRCA1 and BRCA2 and breast cancer incidence: A reviewBishop, D. T. et al. | 1999
- 114
-
Diagnosis of pancreatico-biliary malignancy: Detection of gene mutations in plasma and stoolMulcahy, H. / Farthing, M. J. G. et al. | 1999
- 115
-
Treatment of mantle-cell lymphomas with intermittent two-hour infusion of cladribine as first-line therapy or in first relapseRummel, M. J. / Chow, K. U. / Jaeger, E. / Hossfeld, D. K. / Bergmann, L. / Peters, H.-D. / Hansmann, M.-L. / Meyer, A. / Hoelzer, D. / Mitrou, P. S. et al. | 1999
- 118
-
Usefulness of novel tumour markersRhodes, J. M. et al. | 1999
- 119
-
Docetaxel and cisplatin: An active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies GroupSchoeffsik, P. / Catimel, G. / Planting, A. S. T. / Droz, J.-P. / Verweij, J. / Schrijvers, D. / Gras, L. / Schrijvers, A. / Wanders, J. / Hanauske, A. R. et al. | 1999
- 121
-
Screening mammography for early detection of breast cancerPrimic-Zakelj, M. et al. | 1999
- 122
-
Mechanisms of biliary carcinogenesis: A pathogenetic multi-stage cascade towards cholangiocarcinomaHolzinger, F. / Zgraggen, K. / Buechler, M. W. et al. | 1999
- 123
-
Reply: Treatment of soft-tissue sarcomas: High-dose ifosfamide or combination of ifosfamide and etoposide?Buesa, J. M. et al. | 1999
- 123
-
Treatment of soft-tissue sarcomas: High-dose ifosfamide or combination of ifosfamide and etoposide?Yalctn, S. et al. | 1999
- 124
-
Oral ipriflavone (7-isopropoxy-isoflavone) treatment for elderly patients with resistant acute leukemiasPagano, L. / Teofili, L. / Mele, L. / Piantelli, M. / Ranelletti, F. O. / Equitani, F. / Larocca, L. M. / Leone, G. et al. | 1999
- 125
-
Telomerase or telomersynGuellue, L. H. / Marangoz, S. et al. | 1999
- 127
-
Risk of pancreatic and periampullary cancer following cholecystectomyGullo, L. et al. | 1999
- 129
-
Adjuvant therapy of breast cancer: UpdateCufer, T. et al. | 1999
- 129
-
Gallbladder carcinomaLevin, B. et al. | 1999
- 131
-
Other risk factors for pancreatic cancer: Hormonal aspectsAndren-Sandberg, A. / Hoem, D. / Baeckman, P. L. et al. | 1999
- 134
-
J.K. Harrold, J. Lynn (eds): A good dying. Shaping health care for the last months of lifeNeuenschwander, H. et al. | 1999
- 135
-
Services, costs and appropriate outcomes in end of life careHigginson, I. J. / Edmonds, P. et al. | 1999
- 136
-
Histological and genetic changes in malignant transformation of gallbladder adenomaWatanabe, H. / Dale, K. / Itoi, T. et al. et al. | 1999
- 137
-
Research in low-income countriesMasera, G. / Biondi, A. et al. | 1999
- 139
-
p53-Oriented cancer therapies: Current progressGallagher, W. M. / Brown, R. et al. | 1999
- 139
-
New developments in chemotherapy of advanced breast cancerLebwohl, D. E. / Canetta, R. et al. | 1999
- 140
-
Pancreatic cancer: Clinical presentation, pitfalls and early cluesDiMagno, E. P. et al. | 1999
- 143
-
Biliopancreatic malignancy current diagnostic possibilities: An overviewFerrucci, J. T. et al. | 1999
- 145
-
Role of tumour markers, cytogeneticsLamerz, R. et al. | 1999
- 147
-
Current issues in phase I trials: New study designs and informed consent proceduresCavalli, F. / Sessa, C. et al. | 1999
- 149
-
New approaches in cancer treatmentSikic, B. I. et al. | 1999
- 150
-
Essentials in biliopancreatic staging: A decision analysisOhertop, H. / Gouma, D. J. et al. | 1999
- 151
-
Advanced soft tissue sarcoma: How many more trials with anthracyclines and ifosfamide?Santoro, A. et al. | 1999
- 153
-
Biliopancreatic malignancy: Screening the at risk patient with molecular markersCaldas, C. et al. | 1999
- 155
-
Prolonged neoadjuvant treatment in locally advanced tumours: A novel concept based on biological considerationsLuykx-de Bakker, S. A. / Verheul, H. M. W. / De Gruijl, T. D. / Pinedo, H. M. et al. | 1999
- 157
-
Current chemotherapeutic possibilities in pancreaticobiliary cancerVan Riel, J. M. G. H. / Van Groeningen, C. J. / Pinedo, H. M. / Giaccone, G. et al. | 1999
- 161
-
Use of resources and costs of palliative care with parenteral fluids and analgesics in the home setting for patients with end-stage cancerWitteveen, P. O. / Van Groenestijn, M. A. C. / Blijham, G. H. / Schrijvers, A. J. P. et al. | 1999
- 162
-
Multidrug resistance: A solvable problem?Borst, P. et al. | 1999
- 165
-
Palliation of pain and jaundice: An overviewRussell, R. C. G. et al. | 1999
- 167
-
Acute lymphoblastic leukemia in India: An analysis of prognostic factors using a single treatment regimenAdvani, S. / Pai, S. / Venzon, D. / Adde, M. / Kurkure, P. K. / Nair, C. N. / Sirohi, B. / Banavali, S. D. / Hawaldar, R. / Kolhatkar, B. B. et al. | 1999
- 170
-
Pancreatic endocrine tumors: Recent advancesJensen, R. T. et al. | 1999
- 177
-
Somatostatin receptor imaging and therapy of pancreatic endocrine tumorsVan Eijck, C. H. J. / De Jong, M. / Breentan, W. A. P. et al. et al. | 1999
- 177
-
Economic analysis of a randomized placebocontrolled phase III study of granulocyte macrophage colony stimulating factor in adult patients ( > 55 to 70 years of age) with acute myelogenous leukemiaBennett, C. L. / Stinson, T. J. / Tallman, M. S. / Stadtmauer, E. A. / Marsh, R. W. / Friedenberg, W. / Lazarus, H. M. / Kaminer, L. / Golub, R. M. et al. | 1999
- 182
-
Intraoperative methods to stage and localize pancreatic and duodenal tumorsNorton, J. A. et al. | 1999
- 183
-
Fludarabine and epirubicin in the treatment of chronic lymphocytic leukaemia: A German multicenter phase II studyRummel, M. J. / Kaefer, G. / Pfreundschuh, M. / Jaeger, E. / Reinhardt, U. / Mitrou, P. S. / Hoelzer, D. / Bergmann, L. et al. | 1999
- 185
-
Pancreatic endocrine tumours, immunotherapy and gene therapy: Chemotherapy and interferon therapy of endocrine tumoursVeenhof, C. H. N. et al. | 1999
- 188
-
Gene therapy for pancreatic and biliary malignanciesAspinall, R. J. / Lemoine, N. R. et al. | 1999
- 189
-
Hodgkin's disease in 35 patients with HIV infection: An experience with epirubicin, bleomycin, vinblastine and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSFErrante, D. / Gabarre, J. / Ridolfo, A. L. / Rossi, G. / Nosari, A. M. / Gissclbrecht, C. / Kerneis, Y. / Mazzetti, F. / Vaccher, E. / Talamini, R. et al. | 1999
- 193
-
An overview of preventive strategies for pancreatic cancerLevin, B. et al. | 1999
- 197
-
Breast cancer screening by mammography in Norway. Is it cost-effective?Norum, J. et al. | 1999
- 197
-
Retinoids in pancreatic cancerRiecken, E. O. / Rosewiez, S. et al. | 1999
- 201
-
Preventative strategies for periampullary turnouts in FAPWallace, M. H. / Phillips, R. K. S. et al. | 1999
- 204
-
Remote partial gastrectomy as a risk Factor for pancreatic cancer: Potential for preventive strategiesVan Rees, B. P. / Tascilar, M. / Hruhan, R. H. et al. et al. | 1999
- 205
-
Docetaxel in the community setting: An analysis of 377 breast cancer patients treated with docetaxel (Taxotere[R]) in the UKO'Brien, M. E. R. / Leonard, R. C. / Barrett-Lee, P. J. / Eggleton, S. P. H. / Bizzari, J.-P. et al. | 1999
- 208
-
Prevention of bile duct cancer in primary sclerosing cholangitisHarrison, P. M. et al. | 1999
- 211
-
Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: A multicenter phase II trialMavroudis, D. / Malamos, N. / Alexopoulos, A. / Kourousis, C. / Agelaki, S. / Sarra, E. / Potamianou, A. / Kosmas, C. / Rigatos, G. / Giannakakis, T. et al. | 1999
- 212
-
Local resection of benign periampullary tumorsTreitschke, F. / Beger, H. G. et al. | 1999
- 215
-
Role of radiotherapy, in particular intraluminal brachytherapy, in the treatment of proximal bile duct carcinomaGonzalez Gonzalez, D. / Gouma, D. J. / Rauws, E. A. J. et al. et al. | 1999
- 217
-
Weekly gemcitabine and cisplatin in advanced non-small-cell lung cancer: A phase II studyLippe, P. / Tummuarello, D. / Monterubbianesi, M. C. / Silva, R. R. / Giuliodori, L. / Mari, D. / Santo, A. / Pasini, F. / Cetto, G. L. / Rossi, D. et al. | 1999
- 221
-
Conformal irradiation for hepatobiliary malignanciesGunderson, L. L. / Haddock, M. G. / Foo, M. L. et al. et al. | 1999
- 223
-
A phase I study of docetaxel and 5-fluorouracil in patients with advanced solid malignanciesPetit, T. / Aylesworth, C. / Burris, H. / Ravdin, P. / Rodriguez, G. / Smith, L. / Peacock, N. / Smetzer, L. / Bellet, R. / Von Hoff, D. D. et al. | 1999
- 226
-
Studies of intraoperative radiotherapy in carcinoma of the pancreasSindelar, W. F. / Kinsella, T. J. et al. | 1999
- 231
-
Epstein - Barr virus related hemophagocytic syndrome in a T-cell rich B-cell lymphomaMitterer, M. / Pescosta, N. / Mc Quain, C. / Gebert, U. / Oherkofler, F. / Coser, P. / Knecht, H. et al. | 1999
- 231
-
Chemoradiation for pancreatic and biliary cancer: Current status of RTOG studiesRich, T. A. et al. | 1999
- 234
-
Experimental drugs and drug combinations in pancreatic cancerKroep, J. R. / Pinedo, H. M. / Van Groeningen, C. J. / Peters, G. J. et al. | 1999
- 235
-
Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinomaTan, E.-H. / Khoo, K. S. / Wee, J. / Fong, K. W. / Lee, K. S. / Lee, K. M. / Chua, E. T. / Tan, T. / Khoo-Tan, H. S. / Yang, T. L. et al. | 1999
- 239
-
Surgical possibilities for bile duct cancer: Standard surgical treatmentBenjamin, L. S. et al. | 1999
- 239
-
Prognostic value of cerebrospinal fluid cytology in pediatric medulloblastomaMiralbell, R. / Bieri, S. / Huguenin, P. / Feldges, A. / Morin, A. M. / Garcia, E. / Wagner, H. P. / Wacker, P. / Von der Weid, N. et al. | 1999
- 243
-
Cost comparison between PAV and ICE treatment with peripheral blood progenitor cells (PBPC) reinfusion in small-cell lung cancer (SCLC)Wasserfallen, J.-B. / Rollier, P. / Leyvraz, S. / Perey, L. et al. | 1999
- 243
-
Hepatocellular carcinoma in a patient with Gaucher disease on enzyme supplementation therapyErjavec, Z. / Hollak, C. E. M. / De Vries, E. G. E. et al. | 1999
- 243
-
Local resection of biliopancreatic cancerVan Gulik, T. M. / Gerhards, M. / De Vries, J. et al. et al. | 1999
- 244
-
A specific approval procedure for prescribing albumin: Impact on consumption in a cancer treatment institutionLapierre, V. / Auperin, A. / Benhamou, E. / Tursz, T. et al. | 1999
- 247
-
Sacking of JAMA's Editor-in-Chief| 1999
- 247
-
Standard surgical treatment in pancreatic cancerWagner, M. / Dikopoulos, N. / Kulli, C. et al. et al. | 1999
- 247
-
Private company wins Icelandic gene database| 1999
- 247
-
Role of complementary medicine in the US| 1999
- 247
-
Awards, appointments| 1999
- 247
-
Perhaps not everyone knows that| 1999
- 247
-
Problems and advantages for oncology in the new German Laendern| 1999
- 252
-
Surgical possibilities for pancreatic cancer: Extended resectionKremer, B. / Vogel, I. / Luettges, J. et al. et al. | 1999
- 253
-
C.J. Rosenthal, M. Rotman (eds): Infusion chemotherapy irradiation interactionsBernier, J. et al. | 1999
- 254
-
D.M. Parkin, S.L. Whelan, J. Ferlay (eds): Cancer incidence in five continents, Vol. VIILevi, F. et al. | 1999
- 255
-
Treatment for poor prognosis metastatic germ-cell tumours: Much heat but, as yet, little lightAnthoney, D. A. / Kaye, S. B. et al. | 1999
- 257
-
Complications after resection of biliopancreatic cancerGouma, D. J. / Van Gulik, T. M. / De Wit, L. T. / Ohertop, H. et al. | 1999
- 259
-
What is the role of radiation therapy in locally advanced non-small-cell lung cancer?Livingston, R. B. et al. | 1999
- 261
-
Role of endoscopic stenting in the duodenumCarr-Locke, D. L. et al. | 1999
- 261
-
Cytokine gene therapy: Hopes and pitfallsNanni, P. / Forni, G. / Lollini, P.-L. et al. | 1999
- 265
-
Pain management of pancreatic cancerAndren-Sandberg, A. / Viste, A. / Horn, A. et al. et al. | 1999
- 267
-
Review on evidence-based cancer medicine Selecting computer-based evidence sourcesWyatt, J. C. / Vincent, S. et al. | 1999
- 269
-
Surgical palliative treatment in bilio-pancreatic malignancyGouma, D. J. / Van Geenen, R. / Van Gulik, T. et al. et al. | 1999
- 273
-
Nutritional support during treatment of biliopancreatic malignancyVon Meyenfeldt, M. F. et al. | 1999
- 275
-
Controversies and consensus in the diagnosis, work-up and treatment of gastric lymphoma: An international surveyDe Jong, D. / Aleman, B. M. P. / Taal, B. G. / Boot, H. et al. | 1999
- 278
-
Endoscopic palliative treatment of advanced pancreatic cancer: Thoracoscopic splanchnicectomy and laparoscopic gastrojejunostomyGiraudo, G. / Kazemier, G. / Van Eijck, C. H. J. / Bonjer, H. J. et al. | 1999
- 281
-
Third International Conference on Biology, Prevention and Treatment of Gastrointestinal Malignancies. Cologne, 23 26 September 1998Mayer, R. J. et al. | 1999
- 281
-
Quality of life. nutritional status and gastrointestinal hormone profile following the Whipple procedureMcLeod, R. S. et al. | 1999
- 285
-
The future of surgery for pancreatic cancerSlavin, J. / Ghaneh, P. / Jones, L. et al. et al. | 1999
- 289
-
BOMP/EPI intensive alternating chemotherapy for IGCCC poor-prognosis germ-cell tumors: The Spanish Germ-Cell Cancer Group experience (GG)Germa-Lluch, J. R. / Del Muro, X. G. / Tabernero, J. M. / Sanchez, M. / Aparicio, J. / Alba, E. / Barnadas, A. et al. | 1999
- 291
-
Future role of radiotherapy as a component of treatment in biliopancreatic cancersGunderson, L. L. / Haddock, M. G. / Butch, P. et al. et al. | 1999
- 295
-
A randomised phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectable locoregional non-small-cell lung cancer responding to induction chemotherapySculier, J. P. / Paesmans, M. / Lafitte, J. J. / Baumoehl, J. / Thiriaux, J. / Van Cutsem, O. / Recloux, P. / Bureau, G. / Berchier, M. C. / Zacharias, C. et al. | 1999
- 296
-
Pancreaticobiliary cancer: The future aspects of medical oncologyVan Riel, J. M. G. H. / Giaccone, G. / Pinedo, H. M. et al. | 1999
- 300
-
Biliopancreatic malignancy: Future prospects for progressHo, J. J. L. / Kim, Y. S. et al. | 1999
- 305
-
Combined sequential approach in locally advanced breast cancerZambetti, M. / Oriana, S. / Quattrone, P. / Verderio, P. / Terenziani, M. / Zucali, R. / Valagussa, P. / Bonadonna, G. et al. | 1999
- 305
-
Intravenous and intra-arterial chemotherapeutic possibilities in biliopancreatic cancerVan Groeningen, C. J. et al. | 1999
- 308
-
Risk factors for biliary tract carcinogenesisChapman, R. W. et al. | 1999
- 311
-
Double-blind, randomised, placebo-controlled, dose-finding study of oral ibandronate in patients with metastatic bone diseaseColeman, R. E. / Purohit, O. P. / Black, C. / Vinholes, J. J. F. / Schlosser, K. / Huss, H. / Quinn, K. J. / Kanis, J. et al. | 1999
- 317
-
Incidence of second neoplasms in patients with MALT lymphoma: No increase in risk above the background populationAu, W. Y. / Gascoyne, R. D. / Le, N. / Viswanatha, D. S. / Klasa, R. J. / Gallagher, R. / Connors, J. M. et al. | 1999
- 323
-
Bone marrow derived dendritic cells from patients with multiple myeloma cultured with three distinct protocols do not bear Kaposi's sarcoma associated herpesvirus DNABellos, E. / Gohtschmidt, H. / Doerner, M. / Ho, A. D. / Moos, M. et al. | 1999
- 329
-
Pharmacokinetically guided dose escalation of carboplatin in epithelial ovarian cancer: Effect on drug-plasma AUC and peripheral blood drug-DNA adduct levelsGhazal-Aswad, S. / Tilby, M. J. / Lind, M. / Baily, N. / Sinha, D. P. / Calvert, A. H. / Newell, D. R. et al. | 1999
- 335
-
All-trans-retinoic acid increases cytosine arabinoside cytotoxicity in HL-60 human leukemia cells in spite of decreased cellular ara-CTP accumulationFreund, A. / Roessing, C. / Lanvers, C. / Gescher, A. / Hohenloechter, B. / Juergens, H. / Boos, J. et al. | 1999
- 339
-
Phase I/pharmacokinetic study of the topoisomerase I inhibitor GG211 administered as a 21-day continuous infusionStevenson, J. P. / DeMaria, D. / Sludden, J. / Kaye, S. B. / Paz-Ares, L. / Grochow, L. B. / McDonald, A. / Selinger, K. / Wissel, P. / O'Dwyer, P. J. et al. | 1999
- 345
-
Management of cancer in pregnancy: A case of Ewing's sarcoma of the pelvis in the third trimesterMerimsky, O. / Le Cevalier, T. / Missenard, G. / Lepechoux, C. / Cojean-Zelek, I. / Mesurolle, B. / Le Cesne, A. et al. | 1999
- 351
-
Preliminary results on the activity of oxaliplatin (L-OHP) in refractory/recurrent non-Hodgkin's lymphoma patientsGermann, N. / Brienza, S. / Rotarski, M. / Emile, J. F. / Di Palma, M. / Musset, M. / Reynes, M. / Soulie, P. / Cvitkovic, E. / Misset, J. L. et al. | 1999
- 355
-
Cisplatin-topotecan paclitaxel weekly administration with G-CSF support for ovarian and small-cell lung cancer patients. A dose-finding studyFrasci, G. / Panza, N. / Commella, P. / Carteni, G. / Guida, T. / Nicolella, G. P. / Natale, M. / Lombardi, R. / Apicella, A. / Pacilio, C. et al. | 1999
- 359
-
Reply: Radiotherapy for oesophageal cancerGeraghty, J. G. et al. | 1999
- 359
-
Radiotherapy for oesophageal cancerKal, H. B. / El Sharouni, S. Y. / Wijrdeman, H. K. et al. | 1999
- 360
-
Epirubicin in a breast cancer patient with Gilbert's syndrome: Apparent lack of major pharmacokinetic alterationsRiggi, M. / Poggesi, I. / Regazzi, M. B. / Grasso, S. / Fittipaldo, A. / Seematter, R. J. et al. | 1999
- 361
-
Has the PSA wave already crashed upon us? Changes in the epidemiology of prostate cancer from 1985 to 1994 in central ItalyBarchielli, A. / Crocetti, E. / Zappa, M. et al. | 1999
- 362
-
Acute myeloid leukemia and myelodysplasia in patients with chronic lymphocytic leukemia receiving fludarabine as initial therapyCoso, D. / Costello, R. / Cohen-Valensi, R. / Sainty, D. / Nezri, M. / Gastaut, J. A. / Bouabdallah, R. et al. | 1999
- 364
-
S.A. Curley (ed): Liver cancerMarini, G. et al. | 1999
- 373
-
Rationing in cancer treatment: Is the identification of essential cytotoxic drugs feasible?Sessa, C. et al. | 1999
- 375
-
Drug combinations: Dangerous liaisons or great expectations?Ratain, M. J. et al. | 1999
- 377
-
The third-generation non-steroidal aromatase inhibitors: A review of their clinical benefits in the secondline hormonal treatment of advanced breast cancerHamilton, A. / Piccart, M. et al. | 1999
- 385
-
Essential drugs for cancer therapy. A World Health Organization consultationSikora, K. / Advani, S. / Koroltchouk, V. et al. et al. | 1999
- 391
-
Pharmacokinetic interactions of paclitaxel, docetaxel and their vehicles with doxorubicinColombo, T. / Parisi, J. / Zucchetti, M. et al. et al. | 1999
- 397
-
Vinorelbine as first-line chemotherapy for advanced breast cancer in women 60 years of age or olderVogel, C. / O'Rourke, M. / Winer, E. et al. et al. | 1999
- 403
-
Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: Phase I resultsHolmes, F. A. / Valero, V. / Walters, R. S. et al. et al. | 1999
- 413
-
Metaplastic breast cancer: Prognosis and response to systemic therapyRayson, D. / Adjei, A. A. / Suman, V. J. et al. et al. | 1999
- 421
-
Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal typeHasbini, A. / Mahjoubi, R. / Fandi, A. et al. et al. | 1999
- 427
-
Clinical outcome after autologous transplantation in non-Hodgkin's lymphoma patients with high international prognostic index (IPI)Cortelazzo, S. / Rossi, A. / Bellavita, P. et al. et al. | 1999
- 433
-
Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survivalSarris, A. H. / Kliche, K.-O. / Pethambaram, P. et al. et al. | 1999
- 441
-
Pharmacokinetic schedule finding study of the combination of gemcitabine and cisplatin in patients with solid tumorsVan Moorsel, C. J. A. / Kroep, J. R. / Pinedo, H. M. et al. et al. | 1999
- 449
-
Activity of SCH 66336, a tricyclic farnesyltransferase inhibitor, against human tumor colony-forming unitsPetit, T. / Izbicka, E. / Lawrence, R. A. et al. et al. | 1999
- 455
-
Induction of -glutamylcysteine synthetase gene expression by platinum drugs in peripheral mononuclear cells of lung cancer patientsOguri, T. / Fujiwara, Y. / Miyazaki, M. et al. et al. | 1999
- 461
-
Cytomegalovirus pneumonia in a patient with breast cancer on chemotherapy: Case report and review of the literatureBreathnach, O. / Donnellan, P. / Collins, D. et al. et al. | 1999
- 492
-
E. E. Vokes, H. M. Golomb (eds): Oncologic therapiesGhielmini, M. et al. | 1999
- 493
-
Stem cell transplant at home: Glimpse of the futureReed, E. / Armitage, J. O. et al. | 1999
- 495
-
Antisense - time to shoot the messengerKuss, B. / Cotter, F. et al. | 1999
- 505
-
Redefining the therapeutic goals in chronic lym-phocytic leukemia: Towards an evidence-based, risk-adapted therapyWendtner, C. M. / Schmitt, B. / Wilhelm, M. / Dreger, P. / Montserrat, E. / Emmerich, B. / Hallek, M. et al. | 1999
- 511
-
At home management of aplastic phase following high-dose chemotherapy with stem-cell rescue for hematological and non-hematological malignanciesWestermann, A. M. / Holtkamp, M. M. J. / Linthorst, G. A. M. / Van Leeuwen, L. / Willemse, E. J. M. / Van Dijk, W. C. / Nooijen, W. J. / Baars, J. W. / Schornagel, J. H. / Rodenhuis, S. et al. | 1999
- 519
-
Dose-escalation of CHOP in non-Hodgkin's lymphomaSantoro, A. / Balzarotti, M. / Tondini, C. / Zanini, M. / Giardini, R. / Latteri, F. / Rampinelli, I. / Bufalino, R. et al. | 1999
- 527
-
Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphomaPrzepiorka, D. / Van Besien, K. / Khouri, I. / Hagemeister, F. / Samuels, B. / Folloder, J. / Ueno, N. T. / Molldrem, J. / Mehra, R. / Koerbling, M. et al. | 1999
- 533
-
The high-dose sequential (Milan) chemotherapy/ PBSC transplantation regimen for patients with lymphoma is not cardiotoxicGhielmini, M. / Zappa, F. / Menafoglio, A. / Caoduro, L. / Pampallona, S. / Gallino, A. et al. | 1999
- 539
-
Dose-finding study of epidoxorubicin and doce-taxel as first-line chemotherapy in patients with advanced breast cancerPagani, O. / Sessa, C. / Martinelli, G. / Crivellari, D. / Buonadonna, A. / Thuerlimann, B. / Hess, D. / Borner, M. / Bauer, J. / Zampino, G. et al. | 1999
- 547
-
Front-line treatment of metastatic breast cancer with docetaxel and epirubicin: A multicenter dose-escalation studyKouroussis, C. / Xydakis, E. / Potamianou, A. / Giannakakis, T. / Kakolyris, S. / Agelaki, S. / Sara, E. / Malamos, N. / Alexopoulos, A. / Mavroudis, D. et al. | 1999
- 553
-
Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancerMisset, J. L. / Dieras, V. / Gruia, G. / Bourgeois, H. / Cvitkovic, E. / Kalla, S. / Bozec, L. / Beuzeboc, P. / Jasmin, C. / Aussel, J. P. et al. | 1999
- 561
-
Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-celt lung cancer: A mature follow-up reportFetscher, S. / Brugger, W. / Engelhardt, R. / Kanz, L. / Hasse, J. / Frommhold, H. / Lange, W. / Mertelsmann, R. et al. | 1999
- 569
-
Chemotherapy in carcinomas of unknown primary site: A high-dose intensity policyCuline, S. / Fabbro, M. / Ychou, M. / Romieu, G. / Cupissol, D. / Pujol, H. et al. | 1999
- 577
-
Phase I and pharmacologic study of 9-amino- camptothecin colloidal dispersion formulation in patients with refractory or relapsed acute leukemiaVey, N. / Kantarjian, H. / Tran, H. / Beran, M. / O'brien, S. / Bivins, C. / Giles, F. / Cortes, J. / Cheson, B. / Arbuek, S. et al. | 1999
- 585
-
Synchronous inflammatory breast cancer and advanced ovarian carcinoma: A case with pro- longed disease-free survivalSandor, V. / Reed, E. / Sarosy, G. / Middleton, L. P. / Davis, P. / Kohn, E. et al. | 1999
- 589
-
The metalloproteinase inhibitor batimastat (BB-94) causes cell cycle phase perturbations in ovarian cancer cellsErba, E. / Ronzoni, S. / Bassano, L. / Giavazzi, R. / D'incalci, M. et al. | 1999
- 592
-
L. Balducci, G. H. Lyman, W. B. Ershler (eds): Comprehensive geriatric oncologyObrist, R. et al. | 1999
- 593
-
ESHAP is an active regimen for relapsing Hodgkin's diseaseAparicio, J. / Segura, A. / Garcera, S. / Oltra, A. / Santaballa, A. / Yuste, A. / Pastor, M. et al. | 1999
- 597
-
High-dose paclitaxel plus G-CSF for malignant mesothelioma: CALGB phase II study 9234Vogelzang, N. J. / Herndon, J. E. / Miller, A. / Strauss, G. / Clamon, G. / Stewart, F. M. / Aisner, J. / Lyss, A. / Cooper, M. R. / Suzuki, Y. et al. | 1999
- 601
-
Phase I study of the sequential administration of edatrexate and paclitaxel in patients with advanced solid tumorsRigas, J. R. / Kris, M. G. / Miller, V. A. / Pisters, K. M. W. / Heelan, R. T. / Grant, S. C. / Fennelly, D. W. / Chou, T.-C. / Sirotnak, F. M. et al. | 1999
- 604
-
D. W. Ross: Introduction to oncogenes and molecular cancer medicineFey, M. et al. | 1999
- 605
-
Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 107 patients with non-small-cell lung cancer: A mature follow-up reportFetscher, S. / Brugger, W. / Engelhardt, R. / Kanz, L. / Hasse, J. / Frommhold, H. / Lange, W. / Mertelsmann, R. et al. | 1999
- 609
-
Gemcitabine: A real major advance?Roila, F. / Del Favero, A. / Ballatori, E. et al. | 1999
- 609
-
A new approach to safeguard high standards and cost containment of stem cell transplantation in GermanyDiehl, V. / Walshe, R. / Schmitz, N. et al. | 1999
- 609
-
Reply: Gemcitabine - A real major advance?Thomas, A. / Steward, W. P. et al. | 1999
- 610
-
Anaphylaxis after oxaliplatinMedioni, J. / Coulon, M. A. / Morere, J. F. / Hennebelle, F. / Piperno-Neumann, S. / Breau, J. L. et al. | 1999
- 617
-
L. Degos, D.C. Linch & B. Lowenberg (eds): Textbook of malignant haematologyLongo, D. et al. | 1999
- 619
-
Antibody therapy has arrived. Now where does it fit?Maloney, D. G. et al. | 1999
- 622
-
J.H. Goldie, A.J. Coldman: Drug resistance in cancer. Mechanisms and modelsSpataro, V. et al. | 1999
- 623
-
Neoadjuvant chemotherapy for unresectable liver metastases of colorectal cancer too good to be true?Boner, M. M. et al. | 1999
- 626
-
J.G. Monroe, E.V. Rothenberg (eds): Molecular biology of B-cell and T-cell developmentBertoni, F. et al. | 1999
- 627
-
Depression in breast cancer patients: The need for treatmentAapro, M. / Cull, A. et al. | 1999
- 637
-
Gastric MALT lymphoma: From concept to cureIsaacson, P. G. et al. | 1999
- 647
-
Concurrent platinum-based chemo- and radiotherapy' for locally advanced cervical cancer: A new gold-standard treatment?Mangioni, C. / Landoni, F. / Colombo, A. / Marsiglia, H. / Maggioni, A. / Sasso, G. et al. | 1999
- 649
-
T-cell prolymphocytic leukaemia: Does the expression of CD8+ phenotype justify the identification of a new subtype? Description of two cases and review of the literatureAscani, S. / Leoni, P. / Fraternali Orcioni, G. / Bearzi, L. / Piccioli, M. / Materazzi, M. / Zinzani, P. L. / Gherlinzoni, F. / Falini, B. / Pileri, S. A. et al. | 1999
- 655
-
Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory lowgrade or follicular non-Hodgkin's lymphomaPiro, L. D. / White, C. A. / Grillo-Lopcz, A. J. / Janakiraman, N. / Saven, A. / Beck, T. M. / Varns, C. / Shuey, S. / Czuczman, M. / Lynch, J. W. et al. | 1999
- 663
-
Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgeryGiacchetti, S. / Itzhaki, M. / Gruia, G. / Adam, R. / Zidani, R. / Kunstlinger, F. / Brienza, S. / Alafaci, E. / Bertheault-Cvikovic, F. / Jasmin, C. et al. | 1999
- 671
-
Postoperative radiation and concomitant bolus fluorouracil with or without additional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: A randomized phase III study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G. / Zisiadis, A. / Dafni, U. / Konstantaras, C. / Hatzitheoharis, G. / Liaros, A. / Athanassiou, E. / Dombros, N. / Dervenis, C. / Basdanis, G. et al. | 1999
- 677
-
Long-term evolution of renal function in patients with ovarian cancer after whole abdominal irradiation with or without preceding cisplatinSchneider, D. P. / Marti, H.-P. / Von Briel, C. / Frey, F. J. / Greiner, R. H. et al. | 1999
- 685
-
Sixty percent salvage rate for germ-cell tumours using sequential m-BOP, surgery and ifosfamide-based chemotherapyShamash, J. / Oliver, R. T. D. / Ong, J. / Raja, M. / Edmonds, P. / Gallagher, C. J. / Ostrowski, M. J. / LeVay, J. / Williams, M. et al. | 1999
- 693
-
Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancerPlanting, A. S. T. / Catimel, G. / De Mulder, P. H. M. / De Graeff, A. / Hoeppener, F. / Verweij, J. / Oster, W. / Vermorken, J. B. et al. | 1999
- 701
-
Weekly docetaxel in minimally pretreated cancer patients: A dose-escalation study focused on feasibility and cumulative toxicity of long-term administrationBriasoulis, E. / Karavasilis, V. / Anastasopoulos, D. / Tzamakou, E. / Fountzilas, G. / Rammou, D. / Kostadima, V. / Pavlidis, N. et al. | 1999
- 707
-
Upregulation of basic fibroblast growth factor in breast carcinoma and its relationship to vascular density, oestrogen receptor, epidermal growth factor receptor and survivalSmith, K. / Fox, S. B. / Whitethouse, R. / Taylor, M. / Greenall, M. / Clarke, J. / Harris, A. L. et al. | 1999
- 715
-
Telomerase activity distinguishes between neuroblastomas with good and poor prognosisPoremba, C. / Willenbring, H. / Hero, B. / Christiansen, H. / Schaefer, K.-L. / Brinkschmidt, C. / Juergens, H. / Boecker, W. / Dockhorn-Dworniczak, B. et al. | 1999
- 723
-
The role of chemotherapy in intracranial germinomaHupperets, P. S. G. J. / Defesche, H. F. / De Bruijckere, L. M. / Twijnstra, A. et al. | 1999
- 727
-
A randomized crossover trial assessing patient preference for two different types of portable infusion-pump devicesZahnd, D. / Aebi, S. / Rusterholz, S. / Fey, M. F. / Borner, M. M. et al. | 1999
- 731
-
Progressive disease rate as a surrogate endpoint of phase II trials for non-small-cell lung cancerSekine, I. / Tamura, T. / Kunitoh, H. / Kubota, K. / Shinkai, T. / Kamiya, Y. / Saijo, N. et al. | 1999
- 735
-
Doxil extravasation injury: A case reportLokich, J. et al. | 1999
- 735
-
Five-year leukemia survival by ageLevi, F. / Te, V.-C. / Randimbison, L. / La Vecchia, C. et al. | 1999
- 737
-
A. Manni (ed): Endocrinology of breast cancerColleoni, M. et al. | 1999
- 739
-
Sikora leaves WHO, while reform is being slow| 1999
- 739
-
When bombs put a stop to cancer treatments| 1999
- 739
-
NIH orders Duke Medical Center to stop studies| 1999
- 739
-
Belgium recognizes medical oncology, while postponing decision on cancer centers| 1999
- 739
-
NIH fails to respect deadline for prostate cancer plan| 1999
- 739
-
Cancer survival: dependent on wealth?| 1999
- 746
-
G. A. Noskin (ed): Management of infectious complications in cancer patientsMalinverni, R. et al. | 1999
- 747
-
The challenge of response shift for quality-of-life-based clinical oncology researchSprangers, M. A. G. / Schwartz, C. E. et al. | 1999
- 750
-
M. L. Grossbard (ed): Monoclonal antibody-based therapy of cancerZucca, E. et al. | 1999
- 751
-
Microsatellite instability (MSI) in non-colonic, non-HNPCC tumors: Instable' evidence?Papadopoulos, N. et al. | 1999
- 753
-
Chemotherapy for brain metastases of lung cancerPostmus, P. E. / Smit, E. F. et al. | 1999
- 761
-
Using evaluations of diagnostic tests: Under-standing their limitations and making the most of available evidenceDeeks, J. J. et al. | 1999
- 769
-
Start: A European state-of-the-art on-line instrument for clinical oncologistsCasali, P. / Licitra, L. / Tondini, C. / De Braud, F. / Bruzzi, P. / Costa, A. / Cavalli, F. et al. | 1999
- 775
-
Quality of life as subjective experience: Refraining of perception in patients with colon cancer undergoing radical resection with or without adjuvant chemotherapyBernhard, J. / Huerny, C. / Maibach, R. / Herrmann, R. / Laffer, U. et al. | 1999
- 783
-
Microsatellite instability in gastric MALT lymphomas and in other associated neoplasmsFurlan, D. / Bertoni, F. / Cerutti, R. / Taborelli, M. / Pinotti, G. / Roggero, E. / Cavalli, F. / Bonato, M. / Zucca, E. / Capella, C. et al. | 1999
- 789
-
Is adjuvant tamoxifen used optimally in the treatment of breast cancer? Results of an Italian surveyValentini, M. / Mari, E. / Belfiglio, M. / Nicolucci, A. et al. | 1999
- 795
-
High-dose epirubicin and cyclophosphamide every two weeks as first-line chemotherapy for relapsing metastatic breast cancer patientsCottu, P. H. / Zelek, L. / Extra, J. S. / Espie, M. / Mignot, L. / Morvan, F. / Marty, M. et al. | 1999
- 803
-
Concurrent carboplatin/5-fluorouracil and radiotherapy for recurrent cervical carcinomaManeo, A. / Landoni, F. / Cormio, G. / Colombo, A. / Placa, F. / Pellegrino, A. / Mangioni, C. et al. | 1999
- 809
-
Small-cell lung cancer: Patients included in clinical trials are not representative of the patient population as a wholeCottin, V. / Arpin, D. / Lasset, C. / Cordier, J.-F. / Brune, J. / Chauvin, F. / Trillet-Lenoir, V. et al. | 1999
- 817
-
Possible improved survival of patients with stage IV AJCC melanoma receiving SRL 172 immunotherapy: Correlation with induction of increased levels of intracellular interleukin-2 in peripheral blood lymphocytesMaraveyas, A. / Baban, B. / Kennard, D. / Rook, G. A. W. / Westby, M. / Grange, J. M. / Lydyard, P. / Stanford, J. L. / Jones, M. / Selby, P. et al. | 1999
- 825
-
Application of the International Prognostic Scoring System for myelodysplastic syndromesMaes, B. / Meeus, P. / Michaux, L. / Bijnens, L. / Boogaerts, M. / Hagemeijer, A. / De Wolf-Peeters, C. / Verhoef, G. et al. | 1999
- 831
-
Sequential administration of temozolomide and fotemustine: Depletion of O^6-alkyl guanine-DNA transferase in blood lymphocytes and in tumoursGander, M. / Leyvraz, S. / Decosterd, L. / Bonfanti, M. / Marzolini, C. / Shen, F. / Lienard, D. / Perey, L. / Colella, G. / Biollaz, J. et al. | 1999
- 839
-
A comprehensive assessment of satisfaction with care: Preliminary psychometric analysis in an oncology institute in ItalyBredart, A. / Razavi, D. / Robertson, C. / Didier, F. / Scaffidi, E. / De Haes, J. C. J. M. et al. | 1999
- 847
-
The management of non-small-cell lung cancer: A case historyLittle, F. A. / Gregor, A. et al. | 1999
- 853
-
Phase II study of gemcitabine in ovarian cancerVon Minckwitz, G. / Bauknecht, T. / Visseren-Grul, C. M. / Neijt, J. P. et al. | 1999
- 857
-
Thalidomide in patients with cachexia due to terminal cancer: Preliminary reportBruera, E. / Neumann, C. M. / Pituskin, E. / Calder, K. / Ball, G. / Hanson, J. et al. | 1999
- 861
-
A phase I study of sequential vinorelbine followed by paclitaxelBudman, D. R. / Weiselberg, L. / O'Mara, V. / Buchbinder, A. / Lichtman, S. M. / Donahue, L. / Adams, L. M. et al. | 1999
- 865
-
Does pain at tumor site during vinorelbine infusion affect treatment of recurrent head and neck cancer patients?De Marco, S. / Fabi, A. / Ceribelli, A. / Carlini, P. / Pollera, C. F. / Cognetti, F. et al. | 1999
- 866
-
D. Huhn (ed): New diagnostic methods in oncology and hematologyLeoncini-Franscini, L. et al. | 1999
- 874
-
M.A. Kane, P.A. Bunn (eds): Biology of lung cancerGiaccone, G. et al. | 1999
- 875
-
Intensified CHOP in non-Hodgkin's lymphoma: What we know and what we need to knowSantoro, A. / Balzarotti, M. / Castagna, L. et al. | 1999
- 877
-
Advanced colorectal cancer: Which regimes should we recommend?Koehne, C. H. / Midgley, R. / Seymour, M. / Kerr, D. J. et al. | 1999
- 883
-
Pathologic and technical considerations in the treatment of ductal carcinoma in situ of the breast with lumpectomy and radiation therapyVicini, F. A. / Goldstein, N. S. / Kestin, L. L. et al. | 1999
- 891
-
Recent advances in the treatment of prostate cancerKuyu, H. / Lee, W. R. / Bare, R. / Hall, M. C. / Torti, F. M. et al. | 1999
- 899
-
Communication skills training in oncology: A position paperKiss, A. et al. | 1999
- 903
-
ESTIC position paper: High-dose chemotherapy for breast cancer, investigation should continueCrown, J. / Coiffier, B. / Cortes-Funes, H. / Guillaume, T. / Kanz, L. / Kvalheim, G. / Marty, M. / Symann, M. et al. | 1999
- 907
-
Phase I and subsequent phase II study of filgrastim (r-met-HuG-CSF) and dose intensified cyclophosphamide plus epirubicin in patients with non-Hodgkin's lymphoma and advanced solid tumorsTalbot, S. M. / Westerman, D. A. / Grigg, A. P. / Toner, G. C. / Wolf, M. / Bishop, J. / McKendrick, J. / Zalcberg, J. / Levi, J. / Fox, R. M. et al. | 1999
- 915
-
Concurrent irinotecan and 5-fluorouracil plus levo-folinic acid given every other week in the first-line management of advanced colorectal carcinoma: A phase I study of the Southern Italy Cooperative Oncology GroupComella, P. / Casaretti, R. / De Vita, F. / Avellone, A. / Orditura, M. / Petrillo, A. / Gravina, A. / Faranda, A. / Comis, S. / Comella, G. et al. | 1999
- 923
-
Phase I trial of the selective mitochondrial toxin MKT 077 in chemo-resistant solid tumoursPropper, D. J. / Braybrooke, J. P. / Taylor, D. J. / Lodi, R. / Styles, P. / Cramer, J. A. / Collins, W. C. J. / Levitt, N. C. / Talbot, D. C. / Ganesan, T. S. et al. | 1999
- 929
-
Autologous stem-cell transplant after conventional dose adjuvant chemotherapy for high-risk breast cancer: Impact on the delivery of local-regional radiation therapyMoore, H. C. F. / Mick, R. / Solin, L. J. / Sickles, C. / Mangan, P. A. / Luger, S. M. / Fox, K. R. / Schuchter, L. M. / Loh, E. / Porter, D. L. et al. | 1999
- 937
-
Phase II study of epirubicin and vinorelbine with granulocyte colony-stimulating factor: A high-activity, dose-dense weekly regimen for advanced breast cancerNistico, C. / Garufi, C. / Barni, S. / Frontini, L. / Galla, D. A. P. / Giannarelli, D. / Vaccaro, A. / D'Ottavio, A. M. / Terzoli, E. et al. | 1999
- 943
-
Severe pulmonary toxicity in patients treated with a combination of docetaxel and gemcitabine for metastatic transitional cell carcinomaDunsford, M. L. / Mead, G. M. / Bateman, A. C. / Cook, T. / Tung, K. et al. | 1999
- 949
-
Allelic expression of p73 in human ovarian cancersCodegoni, A. M. / Bertoni, F. / Patregnani, C. / Marinetti, E. / D'Incalci, M. / Broggini, M. et al. | 1999
- 955
-
Analysis of Philadelphia chromosome-negative BCR - ABL-positive chronic myelogenous leukemia by hypermetaphase fluorescence in situ hybridizationSeong, D. / Kantarjian, H. M. / Albitar, M. / Arlinghaus, R. / Xu, J. / Talpaz, M. / Rios, M. B. / Guo, J. Q. / O'Brien, S. / Siciliano, M. et al. | 1999
- 961
-
Hepatitis C infection and B-cell non-Hodgkin's lymphoma in British Columbia: A cross-sectional analysisShariff, S. / Yoshida, E. M. / Gascoyne, R. D. / Le, N. / Connors, J. M. / Middleton, P. J. / Shenkier, T. N. et al. | 1999
- 965
-
Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: A key to study an angiogenic marker in vivo?Wynendaele, W. / Derua, R. / Hoylaerts, M. F. / Pawinski, A. / Waelkens, E. / De Bruijn, E. A. / Paridaens, R. / Merlevede, W. / Van Oosterom, A. T. et al. | 1999
- 973
-
Polymyositis with respiratory muscle weakness requiring mechanical ventilation in a patient with metastatic thymoma treated with octreotideRini, B. I. / Gajewski, T. F. et al. | 1999
- 981
-
A phase II study of the modulation of 5-fluorouracil and folinic acid with high-dose infusional hydroxyurea in metastatic colorectal carcinomaO'Byrne, K. J. / Philip, P. A. / Propper, D. J. / Braybrooke, J. P. / Saunders, M. P. / Bates, N. P. / Taylor, M. A. / Madigan, D. / Genesan, T. S. / Talbot, D. C. et al. | 1999
- 985
-
A phase II study of Tomudex alternated with methotrexate, 5-fluorouracil, leucovorin in first-line chemotherapy of metastatic colorectal cancerCascinu, S. / Silva, R. R. / Labianca, R. / Barni, S. / Mattioli, R. / Martignoni, G. / Frontini, L. / Gasparini, G. / Catalano, V. / Baldelli, A. M. et al. | 1999
- 989
-
Daily times four vinorelbine plus cisplatin in advanced non-small-cell lung cancer: A phase II trial of a novel scheduleSpiridonidis, C. H. / Laufman, L. R. / Jones, J. J. / Rhodes, V. A. et al. | 1999
- 993
-
Primary chemotherapy in operable breast cancer with favorable prognostic factors: A pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acidNole, F. / Minchella, I. / Colleoni, M. / Orvieto, E. / Munzone, E. / De Braud, F. / Peruzzotti, G. / Martinelli, G. / Zampino, M. G. / Catania, C. et al. | 1999
- 997
-
Sudden cardio-pulmonary toxicity following a single infusion of gemcitabineCiotti, R. / Belotti, G. / Facchi, E. / Cantu, A. / D'Amico, A. / Gatti, C. et al. | 1999
- 998
-
Amyloidosis in Hodgkin's and Castleman's diseaseBarista, I. / Benekli, M. / Tekuzman, G. et al. | 1999
- 998
-
Correlation of the serum concentration of vascular endothelial growth factor (VEGF) and hemoglobin levels in patients with epithelial ovarian cancerObermair, A. / Hefler, L. / Nather, A. / Preyer, O. / Kaider, A. et al. | 1999
- 1000
-
N. Neymark (ed): Assessing the economic value of anticancer therapiesTattersall, M. et al. | 1999
- 1006
-
R. N. Proctor (ed): The Nazi war on cancerCavalli, F. et al. | 1999
- 1007
-
Little to learn from phase II trials in small-cell lung cancerLeyvraz, S. / Stupp, R. et al. | 1999
- 1011
-
p53 and chemosensitivityFerreira, C. G. / Tolis, C. / Giaccone, G. et al. | 1999
- 1023
-
Primary extranodal non-Hodgkin's lymphomas. Part 2. Head and neck, central nervous system and other less common sitesZucca, E. / Roggero, E. / Bertoni, F. / Conconi, A. / Cavalli, F. et al. | 1999
- 1035
-
Systematic review and meta-analysis of corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancers 1035Feuer, D. J. / Broadley, K. E. et al. | 1999
- 1043
-
Paclitaxel, gemcitabine, and cisplatin in non- resectable non-small-cell lung cancerSorensen, J. B. / Stenbygaard, L. E. / Dombernowsky, P. / Hansen, H. H. et al. | 1999
- 1051
-
Moderate dose-escalation of combination chemotherapy with concomitant thoracic radiotherapy in limited-disease small-cell lung cancer: Prolonged intrathoracic tumor control and high central nervous system relapse rateVan De Velde, H. / Bosquee, L. / Weynants, P. / Canon, J.-L. / Rosier, J.-F. / Humblet, Y. et al. | 1999
- 1059
-
Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB IV non-small-cell lung cancerIsokangas, O.-P. / Knuuttila, A. / Halme, M. / Maentylae, M. / Lindstroem, I. / Nikkanen, V. / Viren, M. / Joensuu, H. / Mattson, K. et al. | 1999
- 1059
-
High-dose methotrexale and HELP [Holoxan (ifosfamide). Eldesine (vindesine), platinum] doxorubicin in non-metastatic osteosarcoma of the extremity: A French multicentre pilot studyPhilip, T. / Iliescu, C. / Demaille, M.-C. / Pacquement, H. / Gentet, C.-J. / Krakowski, I. / Soler-Michel, P. / Thiesse, P. / Chauvrin, F. / Blay, J.-Y. et al. | 1999
- 1073
-
Factors associated with tumor volume and primary metastases in Ewing tumors. Results from the (EI)CESS studiesHense, H. W. / Ahrens, S. / Paulussen, M. / Lehnert, M. / Juergens, H. et al. | 1999
- 1079
-
CHOP versus MACOP-B in aggressive lymphoma a Nordic Lymphoma Group randomized trialJerkeman, M. / Anderson, H. / Cavallin-Stahl, E. / Dictor, M. / Hagberg, H. / Johnson, A. / Kaasa, S. / Kvaloy, S. / Sundstroem, C. / Akerman, M. et al. | 1999
- 1087
-
Saturable metabolism of continuous high-dose ifosfamide with Mesna and GM-CSH A pharmacokinetic study in advanced sarcoma patientsCerny, T. / Leyvraz, S. / Von Briel, T. / Kuepfer, A. / Schaad, R. / Hsu Schmitz, S.-F. / Honegger, P. / Sessa, C. / Brunner, J. / Boddy, A. V. et al. | 1999
- 1095
-
Awareness of disease among Italian cancer patients: Is there a need for further improvement in patient information?| 1999
- 1101
-
Recurrent inflammation in a site of previous necrotising fasciitis during intravenous CMF chemotherapyMackay, H. J. / Williamson, E. C. M. / Vasey, P. / Harnett, A. N. et al. | 1999
- 1105
-
Radiation myositisWelsh, J. S. / Torre, T. G. / DeWeese, T. L. / O'Reilly, S. et al. | 1999
- 1109
-
Life threatening laryngeal toxicity following treatment with combined chemoradiotherapy for nasopharyngeal cancer: A case report with review of the literatureBaron-Hay, S. / Clifford, A. / Jackson, M. / Clarke, S. et al. | 1999
- 1113
-
Phase I study of Doxil and vinorelbine in metastatic breast cancerBurstein, H. J. / Ramirez, M. J. / Petros, W. P. / Clarke, K. D. / Warmuth, M. A. / Marcom, P. K. / Matulonis, U. A. / Parker, L. M. / Harris, L. N. / Winer, E. P. et al. | 1999
- 1117
-
Complete response of a gastric primary after a short but toxic course of 'S-1'Schoeffski, P. / Chollet, P. / Ganser, A. / Wiese, K.-H. / Rambusch, E. / De Vries, M. J. / Hanauske, A. et al. | 1999
- 1121
-
The clinical utility of the Revised European- American Lymphoma (R.E.A.L.) Classification: Preliminary results of a prospective study in patients with non-Hodgkin's lymphoma from a single centreSweetenham, J. W. / Smartt, P. F. M. / Wilkins, B. S. / Pellatt, J. C. / Smith, J. L. / Ramsay, A. / Whitehouse, J. M. A. et al. | 1999
- 1125
-
Oxaliplatin and paclitaxel combination in patients with platinum-pretreated ovarian carcinoma: An investigator-originated compassionate-use experienceFaivre, S. / Kalla, S. / Cvitkovic, E. / Bourdon, O. / Hauteville, D. / Dourte, L. M. / Bensmaine, M. A. / Itzhaki, M. / Marty, M. / Extra, J. M. et al. | 1999
- 1129
-
Risk of second cancer after testicular cancer in Vaud and Neuchaetel, SwitzerlandLevi, F. / Randimbison, L. / Te, V.-C. / Erler, G. / La Vecchia, C. et al. | 1999
- 1130
-
A. B. Benson, III (ed): Gastrointestinal oncologySaletti, P. et al. | 1999
- 1135
-
P.M. Mauch, J.O. Armitage, V. Diehl et al. (eds): Hodgkin's diseaseCavalli, F. et al. | 1999
- 1136
-
I.F. Tannock, R.P. Hill (eds): The basic science of oncologyD'Incalci, M. et al. | 1999
- 1137
-
An update on thymidylate synthase inhibitorsHughes, A. / Calvert, H. et al. | 1999
- 1141
-
How to interpret the radiological abnormalities that persist after treatment in non-Hodgkin's lymphoma patients'Coiffier, B. et al. | 1999
- 1145
-
High-dose chemotherapy: Is it standard management for any common solid tumorMacNeil, M. / Eisenhauer, E. A. et al. | 1999
- 1163
-
The influence of familial and hereditary factors on the prognosis of breast cancerChappuis, P. O. / Rosenblatt, J. / Foulkes, W. D. et al. | 1999
- 1171
-
Paclitaxel, ifosfamide and cisplatin (TIP) chemotherapy for recurrent or persistent squamous-cell cervical cancerZanetta, G. / Fei, F. / Parma, G. / Balestrino, M. / Lissoni, A. / Gabriele, A. / Mangioni, C. et al. | 1999
- 1175
-
Phase II study of first-line LY231514 (multitargeted antifolate) in patients with locally advanced or metastatic colorectal cancer: An NCIC Clinical Trials Group studyCripps, C. / Burnell, M. / Jolivet, J. / Batist, G. / Lofters, W. / Dancey, J. / Iglesias, J. / Fisher, B. / Eisenhauer, E. A. et al. | 1999
- 1181
-
The role of positron emission tomography (PET) in the management of lymphoma patientsZinzani, P. L. / Magagnoli, M. / Chierichetti, F. / Zompatori, M. / Garraffa, G. / Bendandi, M. / Gherlinzoni, F. / Cellini, C. / Stefoni, V. / Ferlin, G. et al. | 1999
- 1185
-
Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphold tissue (MALT)-typeHoffmann, M. / Kletter, K. / Diemling, M. / Becherer, A. / Pfeffel, F. / Petkov, V. / Chott, A. / Raderer, M. et al. | 1999
- 1191
-
Fludarabine alone compared to CHVP plus interferon in elderly patients with follicular lymphoma and adverse prognostic parameters: A GELA studyCoiffier, B. / Neidhardt-Berard, E. M. / Tilly, H. / Belanger, C. / Bouabdallah, R. / Haioun, C. / Brice, P. / Peaud, P. Y. / Pico, J. L. / Janvier, M. et al. | 1999
- 1199
-
Comparison of the long-term mortality in Hodgkin's disease patients with that of the general populationProvencio, M. / Garcia-Lopez, F. J. / Bonilla, F. / Espana, P. et al. | 1999
- 1207
-
Treatment of multicentric Castleman's disease complicated by the development of non-Hodgkin's lymphoma with high-dose chemotherapy and autologous peripheral stem-cell supportAdvani, R. / Warnke, R. / Rosenberg, S. et al. | 1999
- 1211
-
A phase II study of cisplatin, ifosfamide and doxorubicin in operable primary, axial skeletal and metastatic osteosarcomaVoute, P. A. / Souhami, R. L. / Nooij, M. / Somers, R. / Cortes-Funes, H. / Van der Eijken, J. W. / Pringle, J. / Hogendoorn, P. C. W. / Kirkpatrick, A. / Uscinska, B. M. et al. | 1999
- 1219
-
A randomized, open, parallel-group trial to compare the endocrine effects of oral anastrozole (Arimidex[R]) with intramuscular formestane in postmenopausal women with advanced breast cancerVorobiof, D. A. / Kleeberg, U. R. / Perez-Carrion, R. / Dodwell, D. J. / Robertson, J. F. R. / Calvo, L. / Dowsett, M. / Clack, G. et al. | 1999
- 1227
-
Tumors of the papilla of Vater - inadequate diagnostic impact of endoscopic forceps biopsies taken prior to and following sphincterotomyMenzel, J. / Poremba, C. / Dietl, K.-H. / Boeker, W. / Domschke, W. et al. | 1999
- 1233
-
High antitumour activity of ET743 against human tumour xenografts from melanoma, non-small-cell lung and ovarian cancerHendriks, H. R. / Fiebig, H. H. / Giavazzi, R. / Langdon, S. P. / Jimeno, J. M. / Faircloth, G. T. et al. | 1999
- 1241
-
Cowden disease and Lhermitte Duclos disease, markers of breast carcinoma: Report of two patientsBraud, A. C. / De Rocquancourt, A. / Marty, M. / Espie, M. et al. | 1999
- 1245
-
Bilateral facial nerve palsy secondary to the administration of high-dose paclitaxelLee, R. T. / Oster, M. W. / Balmaceda, C. / Hesdorffer, C. S. / Vahdat, L. T. / Papadopoulos, K. P. et al. | 1999
- 1249
-
Accelerated progression of multiple myeloma during anti-CD20 (Rituximab) therapyKorte, W. / Jost, C. / Cogliatti, S. / Hess, U. / Cerny, T. et al. | 1999
- 1251
-
Substantial activity of budesonide in patients with irinotecan (CPT-11) and 5-fluorouracil induced diarrhea and failure of loperamide treatmentLenfers, B. H. M. / Loeffler, T. M. / Droege, C. M. / Hausamen, T. U. et al. | 1999
- 1255
-
A randomized controlled trial of local injections of hyaluronidase versus placebo in cancer patients receiving subcutaneous hydrationBruera, E. / Neumann, C. M. / Pituskin, E. / Calder, K. / Hanson, J. et al. | 1999
- 1258
-
W.D. Travis, T.V. Colby, B. Corrin et al. (eds): Histological typing of lung and pleural tumoursBaas, P. et al. | 1999
- 1259
-
Weekly paclitaxel plus Herceptin in metastatic breast cancer patients who relapse after stem-cell transplantSporn, J. R. / Bilgrami, S. A. et al. | 1999
- 1259
-
Analysis of BCL-10 gene mutations in ovarian cancer cell linesBertoni, F. / Luminari, S. / Intini, D. / Carobbio, S. / Codegoni, A. M. / Spataro, V. / Neri, A. et al. | 1999
- 1267
-
M. Fiorentino: Diagnostic approach to clinical oncologyCavalli, F. et al. | 1999
- 1268
-
R. Kurzrock, M. Talpaz (eds): Molecular biology in cancer medicineBertoni, F. et al. | 1999
- 1269
-
Neo-adjuvant chemotherapy and bladder preservation in locally advanced transitional cell carcinoma of the bladderBenson, M. C. et al. | 1999
- 1270
-
G.R. Lee, J. Foerster (eds): Wintrobe's clinical hematologyLeoncini-Franscini, L. et al. | 1999
- 1271
-
Neoplastic complications of HIV infectionSpina, M. / Vaccher, E. / Carbone, A. / Tirelli, U. et al. | 1999
- 1287
-
Evolving approaches to cancer drug discovery and development at the National Cancer InstituteSausville, E. A. / Feigal, E. et al. | 1999
- 1293
-
Allogeneic hematopoietic transplantation for mantle-cell lymphoma: Molecular remissions and evidence of graft-versus-malignancyKhouri, I. F. / Lee, M. S. / Romaguera, J. / Mirza, N. / Kantarjian, H. / Korbling, M. / Albitar, M. / Giralt, S. / Samuels, B. / Anderlini, P. et al. | 1999
- 1307
-
Improvements in clinical benefit with vinorelbine in the treatment of hormone-refractory prostate cancer: A phase II trialFields-Jones, S. / Koletsky, A. / Wilding, G. / O'Rourke, M. / O'Rourke, T. / Eckardt, J. / Yates, B. / McGuirt, C. / Burris, H. A. et al. | 1999
- 1311
-
Oxaliplatin added to 5-fluorouracil-based therapy (5-FU +/- FA) in the treatment of 5-FU-pretreated patients with advanced colorectal carcinoma (ACRC): Results from the European compassionate-use programBrienza, S. / Bensmaine, M. A. / Soulie, P. / Louvet, C. / Gamelin, E. / Francois, E. / Ducreux, M. / Marty, M. / Andre, T. / de Braud, F. et al. | 1999
- 1317
-
Survival impact of chemotherapy in patients with colorectal metastases confined to the liver: A re-analysis of 1458 non-operable patients randomised in 22 trials and 4 meta-analysesThirion, P. / Wolmark, N. / Haddad, E. / Buyse, M. / Piedbois, P. et al. | 1999
- 1321
-
Importance-satisfaction discrepancies are associated with health-related quality of life in fiveyear survivors of endocrine gastrointestinal tumoursLarsson, G. / Sjoden, P. O. / Oberg, K. / von Essen, L. et al. | 1999
- 1329
-
Epirubicin, cisplatin and oral UFT with leucovorin (`ECU'): A phase I-II study in patients with advanced upper gastrointestinal tract cancerSeymour, M. T. / Dent, J. T. / Papamichael, D. / Wilson, G. / Cresswell, H. / Slevin, M. L. et al. | 1999
- 1335
-
The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancerBaekelandt, M. / Holm, R. / Trope, C. G. / Nesland, J. M. / Kristensen, G. B. et al. | 1999
- 1343
-
Prognostic factors for subdiaphragmatic involvement in clinical stage I-II supradiaphragmatic Hodgkin's diseaseRueffer, U. / Sieber, M. / Josting, A. / Breuer, K. / Grotenhermen, F. J. / Bredenfeld, H. / Tesch, H. / Nisters-Backes, H. / Engert, A. / Diehl, V. et al. | 1999
- 1349
-
Variability of polymerase chain reaction detection of the bcl-2-IgH translocation in an international multicentre studyJohnson, P. W. / Swinbank, K. / MacLennan, S. / Colomer, D. / Debuire, B. / Diss, T. / Gabert, J. / Gupta, R. K. / Haynes, A. / Kneba, M. et al. | 1999
- 1355
-
The association between physician reimbursement in the US and use of hematopoietic colony stimulating factors as adjunct therapy for older patients with acute myeloid leukemia: Results from the 1997 American Society of Clinical Oncology surveyBennett, C. L. / Bishop, M. R. / Tallman, M. S. / Somerfield, M. R. / Feinglass, J. / Smith, T. J. et al. | 1999
- 1361
-
Protection of acute myeloblastic leukemia cells against apoptotic cell death by high glutathione and gamma-glutamylcysteine synthetase levels during etoposide-induced oxidative stressSiitonen, T. / Alaruikka, P. / Mantymaa, P. / Savolainen, E. R. / Kavanagh, T. J. / Krejsa, C. M. / Franklin, C. C. / Kinnula, V. / Koistinen, P. et al. | 1999
- 1369
-
Cytomegalovirus colitis after administration of docetaxel-5-fluorouracil-cisplatin chemotherapy for locally advanced hypopharyngeal cancerVan den Brande, J. / Schrijvers, D. / Colpaert, C. / Vermorken, J. B. et al. | 1999
- 1373
-
Pancreatitis during therapy of acute myeloid leukemia: Cytarabine related?McGrail, L. H. / Sehn, L. H. / Weiss, R. B. / Robson, M. R. / Antin, J. H. / Byrd, J. C. et al. | 1999
- 1377
-
A phase I-II study of gemcitabine and docetaxel in advanced pancreatic cancer: A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)Cascinu, S. / Gasparini, G. / Catalano, V. / Silva, R. R. / Pancera, G. / Morabito, A. / Giordani, P. / Gattuso, D. / Catalano, G. et al. | 1999
- 1381
-
Pharmacokinetics of interleukin-2 in two anephric patients with metastatic renal cell cancerSchiphorst, P. P. / Chang, P. C. / Clar, N. / Schoemaker, R. C. / Osanto, S. et al. | 1999
- 1385
-
Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: A multicenter phase II study of the Hellenic Cooperative Oncology GroupDimopoulos, M. A. / Bakoyannis, C. / Georgoulias, V. / Papadimitriou, C. / Moulopoulos, L. A. / Deliveliotis, C. / Karayannis, A. / Varkarakis, I. / Aravantinos, G. / Zervas, A. et al. | 1999
- 1389
-
Management of adenocarcinoma of unknown primary with a 5-fluorouracil-cisplatin chemotherapy regimenLofts, F. J. / Gogas, H. / Mansi, J. L. et al. | 1999
- 1393
-
Cisplatin-refractory, HER2/neu-expressing germcell cancer: Induction of remission by the monoclonal antibody TrastuzumabKollmannsberger, C. / Prebetaler, H. / Mayer, F. / Kanz, L. / Bokemeyer, C. et al. | 1999
- 1393
-
Friedreich's ataxia and intrathecal chemotherapy in a patient with lymphoblastic lymphomaDe Pas, T. / Martinelli, G. / De Braud, F. / Peccatori, F. / Catania, C. / Aapro, M. S. / Goldhirsch, A. et al. | 1999
- 1394
-
Hepatic toxicity from cyclophosphamide, methotrexate, fluorouracil (CMF regimen)Locatelli, M. / Colleoni, M. / Noberasco, C. / Nole, F. / Orlando, L. / Munzone, E. / Peruzzotti, G. / Goldhirsch, A. et al. | 1999
- 1396
-
D.H. Johnson, J. Klastersky (eds): Taxanes in lung cancer therapyZappa, F. et al. | 1999
- 1402
-
J.F. Foley, J.M. Vose, J.O. Armitage (eds): Current therapy in cancerCavalli, F. et al. | 1999
- 1403
-
What has prevented Annals of Oncology from reaching an impact factor of 6?Cavalli, F. et al. | 1999
- 1405
-
Individuality versus conformity. Is perfection necessary in staging and prognostic classifications of specific primary extranodal lymphomas?Gospodarowicz, M. et al. | 1999
- 1408
-
J.A. Hickman, C. Dive (eds): Apoptosis and cancer chemotherapyGiaccone, G. / Ferreira, C. et al. | 1999
- 1409
-
Can more breasts be saved if chemotherapy and radiotherapy are administered concomitantly?Kurtz, J. M. et al. | 1999
- 1412
-
S. Johnson, F.N. Johnson (eds): Reviews in contemporary pharmacotherapy: Photodynamic therapyBaas, P. et al. | 1999
- 1413
-
DNA vaccines against cancer: From genes to therapyStevenson, F. K. et al. | 1999
- 1419
-
The World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid TissuesHarris, N. L. / Jaffe, E. S. / Diebold, J. / Flandrin, G. / Muller-Hermelink, H. K. / Vardiman, J. / Lister, T. A. / Bloomfield, C. D. et al. | 1999
- 1433
-
Stage-modified international prognostic index effectively predicts clinical outcome of localized primary gastric diffuse large B-cell lymphomaCortelazzo, S. / Rossi, A. / Roggero, E. / Oldani, E. / Zucca, E. / Tondini, C. / Ambrosetti, A. / Pasini, F. / Pinotti, G. / Bertini, M. et al. | 1999
- 1441
-
Primary gastric non-Hodgkin's lymphoma: Clinical features, management, and prognosis of 185 patients with diffuse large B-cell lymphomaIbrahim, E. M. / Ezzat, A. A. / Raja, M. A. / Rahal, M. M. / Ajarim, D. S. / Mann, B. / Baloush, A. / Stuart, R. K. / Bazarbashi, S. N. et al. | 1999
- 1451
-
Local relapse in primary breast cancer patients with unexcised positive surgical margins after lumpectomy, radiotherapy and chemoendocrine therapyAssersohn, L. / Powles, T. J. / Ashley, S. / Nash, A. G. / Neal, A. J. / Sacks, N. / Chang, J. / Querci della Rovere, U. / Naziri, N. et al. | 1999
- 1457
-
Docetaxel-cisplatin combination (DC) chemotherapy in patients with anthracycline-resistant advanced breast cancerSpielmann, M. / Llombart, A. / Zelek, L. / Sverdlin, R. / Rixe, O. / Le Cesne, A. et al. | 1999
- 1461
-
Weekly gemcitabine and cisplatin combination therapy in patients with transitional cell carcinoma of the urothelium: A phase II clinical trialvon der Maase, H. / Andersen, L. / Crino, L. / Weinknecht, S. / Dogliotti, L. et al. | 1999
- 1467
-
A multi-center prospective phase II study of high-dose chemotherapy in germ-cell cancer patients relapsing from complete remissionRodenhuis, S. / de Wit, R. / de Mulder, P. H. / Keizer, H. J. / Sleijfer, D. T. / Lalisang, R. I. / Bakker, P. J. / Mandjes, I. / Kooi, M. / de Vries, E. G. et al. | 1999
- 1475
-
The course of long-term toxicity in patients treated with cisplatin-based chemotherapy for non-seminomatous germ-cell cancerPetersen, P. M. / Hansen, S. W. et al. | 1999
- 1485
-
Feasibility of tandem autologous stem-cell transplantation (ASCT) in induction failure or very unfavorable (UF) relapse from Hodgkin's disease (HD)Brice, P. / Divine, M. / Simon, D. / Coiffier, B. / Leblond, V. / Simon, M. / Voilat, L. / Devidas, A. / Morschhauser, F. / Rohrlich, P. et al. | 1999
- 1489
-
A randomized EPOCH vs. CHOP front-line therapy for aggressive non-Hodgkin's lymphoma patients: Long-term resultsKhaled, H. M. / Zekri, Z. K. / Mokhtar, N. / Ali, N. M. / Darwish, T. / Elattar, I. / Gaafar, R. / Moawad, M. S. et al. | 1999
- 1493
-
Pentostatin in T-cell malignancies - a phase II trial of the EORTCHo, A. D. / Suciu, S. / Stryckmans, P. / De Cataldo, F. / Willemze, R. / Thaler, J. / Peetermans, M. / Dohner, H. / Solbu, G. / Dardenne, M. et al. | 1999
- 1499
-
Nasopharyngeal carcinoma in children under 15 years of age: A retrospective review of 65 patientsSahraoui, S. / Acharki, A. / Benider, A. / Bouras, N. / Kahlain, A. et al. | 1999
- 1503
-
Gemcitabine-cisplatin: A schedule finding studyKroep, J. R. / Peters, G. J. / van Moorsel, C. J. / Catik, A. / Vermorken, J. B. / Pinedo, H. M. / van Groeningen, C. J. et al. | 1999
- 1511
-
The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: A randomized double-blind controlled trialMazzocato, C. / Buclin, T. / Rapin, C. H. et al. | 1999
- 1515
-
Leukoencephalopathy in multiple myeloma: Two case reportsLebrun, C. / Chanalet, S. / Frenay, M. / Chatel, M. et al. | 1999
- 1519
-
Primary T-cell lymphoma of central nervous system (PTCLCNS): A case with unusual presentation and review of the literaturePulsoni, A. / Gubitosi, G. / Rocchi, L. / Iaiani, G. / Martino, B. / Carapella, C. / Vaccaro, F. et al. | 1999
- 1525
-
Rituximab therapy in Waldenstrom's macroglobulinemia: Preliminary evidence of clinical activityByrd, J. C. / White, C. A. / Link, B. / Lucas, M. S. / Velasquez, W. S. / Rosenberg, J. / Grillo-Lopez, A. J. et al. | 1999
- 1529
-
Radiation pneumonitis after local-regional radio-therapy following autologous stem-cell transplant for high-risk breast cancerMarti, J. L. / Tres, A. / Velilla, C. / Lopez, P. / Garcia, M. D. / Isla, D. / Mayordomo, J. I. et al. | 1999
- 1529
-
Urinary bladder cancer death rates in EuropeLa Vecchia, C. / Lucchini, F. / Negri, E. / Levi, F. et al. | 1999
- 1530
-
Elevation of urinary porphyrin levels following gemcitabine administrationDaniele, B. / De Vivo, R. et al. | 1999
- 1531
-
Docetaxel and epirubicin plus G-CSF mobilize hematopoietic progenitors in breast cancerPierelli, L. / Leone, G. / Cortesi, E. / Martelli, O. / Perillo, A. / Mancuso, S. / Scambia, G. et al. | 1999
- 1532
-
M. Talpaz, H.M. Kantarjian (eds): Medical management of chronic myelogenous leukemiaKovacsovics, T. et al. | 1999
-
VII. International Conference on Malignant Lymphoma| 1999